Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Zhenyu Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1733-5806; OpenAlex author ID A5101675190. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study. Co-author DOI 10.1093/oncolo/oyae171↗
  2. Clinicopathological Features, Immune Infiltration Landscape and Involved Signaling Pathways of the desmogleins family in Pancreatic Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-2971625/v1↗
  3. Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic ca… Last author DOI 10.1186/s12885-021-08605-x↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun Xue · 1 shared paper, 2024 · strength 0.19
  2. Tao Zhang · 1 shared paper, 2024 · strength 0.19
  3. Min Jin · 1 shared paper, 2024 · strength 0.19
  4. Hongli Liu · 1 shared paper, 2024 · strength 0.19
  5. Jianli Hu · 1 shared paper, 2024 · strength 0.19
  6. Xu Che · 1 shared paper, 2023 · strength 0.18
  7. Yongxing Du · 1 shared paper, 2023 · strength 0.18
  8. Yunjie Duan · 1 shared paper, 2023 · strength 0.18
  9. Dandan Yu · 1 shared paper, 2021 · strength 0.13
  10. Jiayuan Chen · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.